Literature DB >> 10380713

Treatment of schizophrenia 1999. The expert consensus guideline series.

.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10380713

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  21 in total

Review 1.  Pharmacoeconomics of long-acting risperidone: results and validity of cost-effectiveness models.

Authors:  Alan Haycox
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment.

Authors:  Nurith Amitai; Athina Markou
Journal:  Pharmacol Biochem Behav       Date:  2008-09-08       Impact factor: 3.533

Review 3.  Haloperidol plus promethazine for psychosis-induced aggression.

Authors:  Gisele Huf; Jacob Alexander; Pinky Gandhi; Michael H Allen
Journal:  Cochrane Database Syst Rev       Date:  2016-11-25

Review 4.  Managing suicide risk in patients with schizophrenia.

Authors:  John Kasckow; Kandi Felmet; Sidney Zisook
Journal:  CNS Drugs       Date:  2011-02       Impact factor: 5.749

5.  Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine.

Authors: 
Journal:  BMJ       Date:  2003-09-27

6.  Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine.

Authors:  Nirmal S Raveendran; Prathap Tharyan; Jacob Alexander; Clive Elliot Adams
Journal:  BMJ       Date:  2007-10-22

7.  Anti-psychotic prescription pattern: A preliminary survey of Psychiatrists in India.

Authors:  Sandeep Grover; Ajit Avasthi
Journal:  Indian J Psychiatry       Date:  2010-07       Impact factor: 1.759

Review 8.  Assessing the value of antipsychotics for treating schizophrenia: the importance of evaluating and interpreting the clinical significance of individual service costs.

Authors:  Sandra L Tunis; Haya Ascher-Svanum; Michael Stensland; Bruce J Kinon
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

9.  Assessing conformance to medication treatment guidelines for schizophrenia in a community mental health center (CMHC).

Authors:  Mona Goldman; Daniel J Healy; Timothy Florence; Lorelei Simpson; Karen K Milner
Journal:  Community Ment Health J       Date:  2003-12

Review 10.  Management of the negative symptoms of schizophrenia: new treatment options.

Authors:  Hans-Jürgen Möller
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.